RemeGen Co., Ltd. (9995.HK) Financials

9995.HK Assets vs Liabilities
DateAssetsLiabilities
Dec. 31, 2025 8.1 billion 4.0 billion
Sept. 30, 2025 6.5 billion 4.0 billion
June 30, 2025 6.4 billion 3.8 billion
March 31, 2025 5.7 billion 3.8 billion

9995.HK Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
Dec. 31, 2025 -205.1 million ?
Sept. 30, 2025 441.8 million ?
June 30, 2025 -155.7 million 13.3 million
March 31, 2025 -239.8 million ?

9995.HK Net Income
Graph available only for paid members. Upgrade to see it.
DateNet Income
Dec. 31, 2025 1.4 billion
Sept. 30, 2025 -110.4 million
June 30, 2025 -214.1 million
March 31, 2025 -272.2 million

9995.HK Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
Dec. 31, 2025 2.7 billion 814.9 million 22.0 million
Sept. 30, 2025 1.3 billion 761.0 million 27.6 million
June 30, 2025 1.4 billion 894.9 million 77.0 million
March 31, 2025 772.9 million 1.1 billion 36.3 million

9995.HK Shares Outstanding

No data available :(

9995.HK Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
Dec. 31, 2025 27.9 million - - -
Sept. 30, 2025 61.2 million 265.9 million 406.4 million -
June 30, 2025 93.0 million 348.8 million 363.2 million 301.4 million
March 31, 2025 38.2 million 352.2 million 360.3 million 268.5 million

9995.HK Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
Dec. 31, 2025 1.7 billion 212.9 million
Sept. 30, 2025 674.7 million 104.4 million
June 30, 2025 626.7 million 95.3 million
March 31, 2025 563.3 million 94.3 million

9995.HK

Price: HK$74.55

52 week price:
15.50
126.60

Earnings Per Share: -2.40 HKD

P/E Ratio: -35.54

Exchange: HKG

Sector: Healthcare

Industry: Biotechnology

Market Capitalization: 46.9 billion

Links: